AIOSYN
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer and CKD drug development studies for biopharma.
AIOSYN
Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Machine Learning Medical Device Pharmaceutical
Founded:
2021-07-30
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.aiosyn.org
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M EUR
Technology used in webpage:
Domain Not Resolving Google Analytics Nginx Person Schema Gravatar Profiles BootstrapCDN Varnish Styled Components Statsig
Similar Organizations
Perabiom
Artificial intelligence, Biotechnology, Medical diagnostics, Medical devices
Reti Health
Preventing heart attacks and strokes with cardiovascular health screening from retinal images
Socmedica
artificial intelligence (AI) capable of predicting risks in the of field of medicine, biology, and pharmacology with clinical experience.
Current Employees Featured
Wouter Bulten Co-founder and Chief Innovation Officer @ Aiosyn
Co-founder and Chief Innovation Officer
2021-08-01
David Tellez Co-founder and Chief Technology Officer @ Aiosyn
Co-founder and Chief Technology Officer
2021-07-01
Founder
Investors List
Health Innovations
Health Innovations investment in Seed Round - Aiosyn
LUMO labs
LUMO labs investment in Seed Round - Aiosyn
OostNL
OostNL investment in Seed Round - Aiosyn
LUMO labs
LUMO labs investment in Pre Seed Round - Aiosyn
OostNL
OostNL investment in Pre Seed Round - Aiosyn
Official Site Inspections
http://www.aiosyn.org Semrush global rank: 13.97 M Semrush visits lastest month: 87
Unable to get host informations!!!
More informations about "Aiosyn"
Aiosyn Homepage - Aiosyn
Aiosyn’s NephroPath platform uses deep learning to analyze kidney structures and quantify lesions that impact kidney health. Co-developed with kidney pathology experts, the platform is …See details»
Aiosyn - Crunchbase Company Profile & Funding
Organization. Aiosyn . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Aiosyn uses artificial intelligence to develop …See details»
About - Aiosyn
Aiosyn was founded as a spin-off from the Computational Pathology research group of Radboud University Medical Center, one of the front-runners in the field. We build upon 20+ years of …See details»
Team - Aiosyn
Latest News: Aiosyn launches AiosynQC Pulse for external digital slide quality assessments, providing pathology labs with insights for slide quality improvement Learn more. Solutions for. …See details»
Aiosyn Company Profile 2024: Valuation, Funding & Investors
Aiosyn General Information Description. Developer of a medical analysis platform designed to accelerate the adoption of artificial intelligence in pathology diagnostics. The company's …See details»
About Aiosyn - Radboudumc
Aiosyn is awarded the NWO Take Off Phase II grant 23 December 2021 Aiosyn, a Radboudumc spin-off company that develops AI-powered pathology algorithms for clinical diagnostics and …See details»
Aiosyn - Pathology News
Aiosyn provides solutions for clinical diagnostics that address workflow inefficiencies by streamlining the pathological examination process, enhancing overall quality, and reducing …See details»
Aiosyn - Products, Competitors, Financials, Employees, …
About Aiosyn. Aiosyn is a healthtech company focused on developing precision pathology software solutions for the healthcare sector. The company offers AI-powered algorithms that …See details»
Aiosyn - GitHub
Aiosyn is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. - Aiosyn. ... This organization has no …See details»
Aiosyn, Radboudumc, and Pathologie-DNA are …
Nijmegen, Netherlands – Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to …See details»
Aiosyn announces the formation of a Scientific …
Oct 12, 2023 Nijmegen, The Netherlands – Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the formation of its Scientific Advisory Board. The …See details»
Aiosyn raises EUR 2 million to develop AI-powered algorithms - To ...
Dec 21, 2022 Aiosyn’s algorithms will work in close synergy with pathologists to address the growing workload and the demand to further improve diagnostic precision. AI helps with better …See details»
Aiosyn And Physiogenex Partner To Enhance Kidney Disease Drug ...
Mar 14, 2024 Nijmegen, The Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced …See details»
Dutch startup Aiosyn raises €2 million to harness the power of AI …
Dec 22, 2022 The tremendous development Aiosyn has made in the last year solidifies this belief, and for this reason, the company has the support of Oost NL.” AI for Pathology …See details»
Aiosyn: The benefits of AI implementation in mitotic figure counting
Apr 12, 2024 From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various …See details»
Aiosyn’s AI-powered Mitosis Detection Solution is Now Accessible …
May 2, 2024 Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the integration of its …See details»
Aiosyn Launches AiosynQC Pulse for External Digital Slide Quality ...
Nov 29, 2024 Aiosyn’s digital slide quality assessments use AI-powered artifact detection to deliver actionable key performance indicators (KPIs), helping labs improve pre-analytical …See details»
New start-up Aiosyn will bring AI research into pathology …
Sep 21, 2021 Aiosyn’s management team consists of Patrick de Boer, Jeroen van der Laak, David Tellez and Wouter Bulten. Katrien Grünberg, Geert Litjens and Francesco Ciompi are …See details»
Aiosyn leverages AI to get faster cancer diagnoses - IO
Mar 2, 2022 The Nijmegen start-up Aiosyn, a spin-off of the Radboudumc in The Netherlands, is developing an AI platform that helps pathologists reach diagnoses faster and more …See details»
Aiosyn Introduces Kidney AI Platform To Revolutionize Renal …
Sep 19, 2023 Healthy and sclerotic glomeruli in a renal biopsy are identified with Aiosyn’s solutions powered by AI Nijmegen, Netherlands – Aiosyn, a medical software company …See details»